EPSTEIN BARR VIRUS
Clinical trials for EPSTEIN BARR VIRUS explained in plain language.
Never miss a new study
Get alerted when new EPSTEIN BARR VIRUS trials appear
Sign up with your email to follow new studies for EPSTEIN BARR VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could this mRNA shot stop the virus behind mono and cancer?
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage study is testing a new mRNA vaccine called mRNA-1189 to see if it is safe and can protect against Epstein-Barr virus (EBV). About 120 healthy adults aged 18 to 30 will receive the vaccine either under the skin or into a muscle. Researchers will monitor side effec…
Matched conditions: EPSTEIN BARR VIRUS
Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 15, 2026 19:07 UTC
-
Massive health survey aims to uncover hidden disease hotspots
Knowledge-focused Recruiting nowThis study will test 10,000 people in Cambodia for antibodies against 57 different infectious diseases, including dengue, flu, and malaria. The goal is to learn how these diseases spread in communities and which ones are most common. This information will help health officials de…
Matched conditions: EPSTEIN BARR VIRUS
Sponsor: Institut Pasteur du Cambodge • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:07 UTC